| abstract |
The invention concerns the use of the compounds of formula In n wherein the substituents have various significances, in free form or salt form as appropriate, in the treatment of atherosclerosis. n It also concerns pharmaceutical compositions comprising a compound selected from a subgroup thereof. It further concerns a subgroup of compounds thereof, which are novel, per se. n The compounds of formula I can be prepared in conventional manner, e.g. by reaction of an isothiocyanate with an amine or conversion of an urea to a thiourea. |